Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02111980 · ClinicalTrials.gov registry record · NA

RF Surgical Sponge-Detecting System on the Function of Pacemakers and Implantable Cardioverter Defibrillators

A NA study of Heart Failure and Cardiomyopathy, sponsored by University of California, San Diego.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT02111980 is a NA study of Heart Failure and Cardiomyopathy that has completed, run by University of California, San Diego. The registered enrollment target is 50 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02111980, a NA study of Heart Failure and Cardiomyopathy, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

If a surgical sponge is mistakenly left inside a patient's body after a surgical procedure, it can cause a serious infection. To prevent this from happening, a new device has been developed that uses radiofrequency (RF) signals to detect the presence of surgical sponges inside the body. The device is now being used routinely to make sure that no sponges are left inside a patient at the end of an operation. However, the RF device has not been implemented in procedures for patients with cardiac implantable electronic devices (CIEDs). While the device is FDA approved for use, there is a theoretical concern that the radiofrequency signals used to detect the sponges will change the settings on the pacemaker or the defibrillator. Changing the settings on a pacemaker might make it pace the heart too quickly or too slowly, while changing the settings on a defibrillator might cause unnecessary shocks or prevent it from shocking the heart if the patient were to have cardiac arrest. The purpose of this study is to test whether the radiofrequency device used to detect sponges can cause a clinically significant change to the settings on pacemakers and defibrillators. To minimize potential risk, the device will be tested only on patients who are having the pacemaker or defibrillator removed or replaced as part of their regular medical care, either because it is infected or because the battery has worn out. Before the pacemaker or defibrillator is removed, the settings will be carefully and completely recorded and the radiofrequency device will be used to scan the body for sponges as it would be done during normal operation. After the pacemaker or defibrillator is taken out, the settings will again be recorded and compared to the settings before the scan. In a standard device removal procedure, no clinically significant change in CIED settings would be expected. If a new pacemaker or defibrillator is implanted in the patient, it will not be exposed to the detection device at all

Interventions

  • DEVICE RF Assure Scanning

Study Locations (1)

California

  • UCSD Sulpizio Cardiovascular Center - La Jolla

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2014-03
Est. Completion 2015-05
Phase NA

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT02111980

The ClinicalTrials.gov registry entry for NCT02111980 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (98% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which RF Assure Scanning is the first listed.

NCT02111980 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02111980 about?

NCT02111980 is a clinical study titled "RF Surgical Sponge-Detecting System on the Function of Pacemakers and Implantable Cardioverter Defibrillators". If a surgical sponge is mistakenly left inside a patient's body after a surgical procedure, it can cause a serious infection. To prevent this from happening, a new device has been developed that uses radiofrequency (RF) signals to detect the presence of surgical sponges inside the body. The device i...

What is the current status of trial NCT02111980?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2014-03. Estimated completion is 2015-05.

What conditions does trial NCT02111980 study?

This clinical trial studies the following conditions: Heart Failure, Cardiomyopathy, Cardiac Arrhythmia, Chronic Thromboembolic Pulmonary Hypertension.

What interventions are being tested in trial NCT02111980?

The interventions under investigation include: RF Assure Scanning (DEVICE).

Who is sponsoring clinical trial NCT02111980?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02111980 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.